Repository navigation
benchmark(commercial_ehr): Epic and Oracle Health sandbox terms and write support - #1650
Merged
Merged
Conversation
…nd Oracle Health Epic's open sandbox is a go: Patient, Observation and AllergyIntolerance accept writes, and the terms allow naming Epic factually. It has no AuditEvent search or _history, so the verifier's change feed needs a narrower mode there. Oracle Health is a no-go without written approval: its API terms bar benchmarking and public announcements.
abrichr
changed the title
abrichr
changed the title
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Add this suggestion to a batch that can be applied as a single commit.This suggestion is invalid because no changes were made to the code.Suggestions cannot be applied while the pull request is closed.Suggestions cannot be applied while viewing a subset of changes.Only one suggestion per line can be applied in a batch.Add this suggestion to a batch that can be applied as a single commit.Applying suggestions on deleted lines is not supported.You must change the existing code in this line in order to create a valid suggestion.Outdated suggestions cannot be applied.This suggestion has been applied or marked resolved.Suggestions cannot be applied from pending reviews.Suggestions cannot be applied on multi-line comments.Suggestions cannot be applied while the pull request is queued to merge.Suggestion cannot be applied right now. Please check back later.
Phase 1 of qualifying the verifier against a commercial EHR sandbox: research only, no accounts created. Adds
packages/flow/benchmark/commercial_ehr/FINDINGS.md: Epic is a go, Oracle Health is a no-go without written approval, athenahealth was not assessed. Phase 2 (the Epic run) is in a follow-up PR.